Arovella Therapeutics (ARVEF) Q1 2025 Earnings

27FebConfirmed
Q3 2024
Q1 2025
-0
-0
-0
-0

Details

Expected EPS
-0.00123734
Actual EPS
-0.000866138
Surprise EPS
0
Surprise Percent
+30%

Description

Arovella Therapeutics (ARVEF) has reported earnings of -0.000866138 per share for Q1 2025.

0 Comments

Share your thoughts